Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Mabala Tshepang headshot

Tshepang

Mabala

,

MD

University of Cape Town
Cape Town
,
South Africa
2026 Fellow
Dr. Tshepang Mabala is a registrar in Dermatology at Groote Schuur Academic Hospital and Red Cross War Memorial Children’s Hospital, Western Cape, South Africa. She works in both adult and pediatric outpatient departments, where she manages a wide range of dermatological conditions. Her current research for her Master of Medicine (Dermatology) degree at the University of Cape Town focuses on the incidence and prevalence of psoriatic arthritis in the psoriasis population. She has developed a keen interest in psoriasis comorbidities, treatment, and the psychosocial challenges faced by patients in resource-limited countries. Through her research, a combined Dermatology–Rheumatology clinic was established to review patients with early features of psoriatic arthritis, enabling early detection and prompt treatment via a multidisciplinary team approach. She is a winner of the 2025 Dermatology Society of South Africa Research Award. Dr. Mabala actively participates in the South African Psoriasis Association’s patient support group, serving as a support doctor and an avid advocate for patients. She is currently establishing a psoriasis registry for patients attending the outpatient clinic at Groote Schuur Hospital, with the aim of laying the foundation for a national psoriasis registry in South Africa.

Dr. Mabala will study with IPC Councilor Alice Gottlieb at UT Southwestern Medical Center in Dallas, Texas, United States.
Last Updated:
12/29/2025

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026